Clinical Utility of Procalcitonin and Its Association With Pathogen Types and Prognosis in Patients With Bloodstream Infection
Journal of Clinical Laboratory Analysis · 11.11.2026
DOI: 10.1002/jcla.70398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, online erschienen am 11.11.2026. Verfasst von Wei Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: 345 Talent Project of Shengjing Hospital.
Abstract (Originalsprache)
Background
Procalcitonin (PCT) levels have been reported less frequently in polymicrobial bloodstream infection (BSI). The purpose of this study is to assess the value of serum PCT in early identifying pathogen types isolated from BSI including mixed microorganisms and predicting patient outcomes.
Methods
Between January 2012 and December 2018, medical records were collected on adult patients with BSI who met the inclusion criteria and underwent PCT testing within 24 h of the onset.
Results
817 episodes were included in the study. The 30‐day mortality rate among patients with polymicrobial BSI was notably elevated compared to those with monomicrobial BSI (50.0% vs. 16.9%, p < 0.001). A notable increase in PCT levels was detected in non‐survivors when compared to survivors (6.06 ng/mL vs. 1.23 ng/mL, p < 0.001). Receiver operating characteristic curve (ROC) analysis showed that a PCT level of 3.79 ng/mL yielded a 49.4% sensitivity, a 77.6% specificity, an 83.0% positive predictive value (PPV) and a 40.9% negative predictive value (NPV) for gram‐negative or multiple bacteria BSI (the area under the curve 0.642, p = 0.0199). Additionally, the areas under the ROC curve of PCT predicting 30‐day mortality was 0.674 ( p = 0.0238) with a cut‐off value of 1.11 ng/mL, a sensitivity of 79.9%, a specificity of 49.0%, a PPV of 25.9% and a NPV of 91.6%.
Conclusions
The significant elevation of PCT levels may contribute to early distinguishing gram‐negative or polymicrobial BSIs and outcome evaluation with low‐to‐moderate discriminatory ability, thus optimizing antibiotic treatment regimens and improving the prognosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
- Department of Pulmonary and Critical Care Medicine, Liaoyang Central Hospital, Liaoyang, Liaoning, China.
- Department of Crirical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xian, Shanxi, China.
- Department of Critical Care Medicine, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China.
- Department of Critical Care Medicine, Inner Mongolia Maternal and Child Health Care Hospital, Hohhot, Inner Mongolia, China.
- Department of Pulmonary and Critical Care Medicine, Chengdu Seventh People's Hospital, Chengdu, China.
ORCID-Profile: Rui Zheng
Förderung
- 345 Talent Project of Shengjing Hospital
Zitieren
APA
Zhang, W., Liu, Q., Song, X., Wu, H., Zhang, D., Li, H., Chen, R., Yu, X., & Zheng, R. (2026). Clinical Utility of Procalcitonin and Its Association With Pathogen Types and Prognosis in Patients With Bloodstream Infection. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.70398
Vancouver
Zhang W, Liu Q, Song X, Wu H, Zhang D, Li H, et al. Clinical Utility of Procalcitonin and Its Association With Pathogen Types and Prognosis in Patients With Bloodstream Infection. Journal of Clinical Laboratory Analysis. 2026. doi:10.1002/jcla.70398
BibTeX
@article{Zhang2026,
author = {Zhang, Wei and Liu, Quanbo and Song, Xingpeng and Wu, Hao and Zhang, Dan and Li, Huan and Chen, Rui and Yu, Xiaoxu and Zheng, Rui},
title = {Clinical Utility of Procalcitonin and Its Association With Pathogen Types and Prognosis in Patients With Bloodstream Infection},
journal = {Journal of Clinical Laboratory Analysis},
year = {2026},
doi = {10.1002/jcla.70398}
}
EUVIMED